Status:
TERMINATED
Mind-Body Intervention for Veterans With PTSD
Lead Sponsor:
University of Utah
Conditions:
Stress Disorders, Post-Traumatic
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This pilot project evaluates the efficacy of a mind-body awareness training intervention, Mind-Body Bridging (MBB), in veteran patients with PTSD and comorbid symptoms. Evidence for relative therapeut...
Detailed Description
PTSD is a difficult illness to treat and there is a lack of interventions that effectively reduce it. In recent years, attention has focused on treating PTSD patients by including a sleep-focused inte...
Eligibility Criteria
Inclusion
- Inclusion of subjects will be based on: pre-screening score of 50 or greater on the PTSD Checklist for Military (PCL-M). Since we are also interested in the effects of MBB on co-morbid illnesses besides PTSD, we will include subjects who present with other behavioral health conditions, including sleep disturbance, depression, anxiety, pain, and any general medical conditions, except as defined as exclusion criteria. Subjects using anti-anxiety, anti-depressants, sleep and pain medications, and other medications for any condition that is not under exclusion criteria will be admitted to the study. Participants must be willing to commit to the 10-week course and complete all outcome measures, be literate in English and able to provide informed consent.
- Participants will be asked to refrain from engaging in other PTSD treatment programs for the duration of the proposed study, but can remain on their medications and continue with their usual medical or mental health care. They will also be allowed to continue with other activities (such as physical exercise, meditation, yoga, etc.), which they may have already incorporated into their life.
Exclusion
- A patient will be excluded from the study under the following conditions:
- currently enrolled in active PTSD treatment program.
- identifying with major psychopathology (i.e., schizophrenia, mania, or poorly controlled bipolar disorder, borderline or antisocial personality disorder) and was psychiatrically hospitalized within the past 90 days.
- cognitive impairment or dementia.
- severe medical disease such as uncontrolled hypertension or diabetes, or terminal illness, e.g., cancer.
- active substance abuse disorder
- suicidal ideation with intent
Key Trial Info
Start Date :
April 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2017
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT02224989
Start Date
April 1 2015
End Date
December 31 2017
Last Update
May 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Salt Lake City Veterans Affairs Health Care System
Salt Lake City, Utah, United States, 84148